109 related articles for article (PubMed ID: 26925786)
21. Transcriptional activation of OCT4 by the ETS transcription factor PEA3 in NCCIT human embryonic carcinoma cells.
Park SW; Do HJ; Ha WT; Han MH; Park KH; Song H; Kim NH; Kim JH
FEBS Lett; 2014 Aug; 588(17):3129-36. PubMed ID: 24983502
[TBL] [Abstract][Full Text] [Related]
22. Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease.
Zhang HJ; Siu MK; Wong ES; Wong KY; Li AS; Chan KY; Ngan HY; Cheung AN
Placenta; 2008 Jun; 29(6):549-54. PubMed ID: 18440631
[TBL] [Abstract][Full Text] [Related]
23. Methylation-induced silencing of maspin contributes to the proliferation of human glioma cells.
Xu L; Liu H; Yu J; Wang Z; Zhu Q; Li Z; Zhong Q; Zhang S; Qu M; Lan Q
Oncol Rep; 2016 Jul; 36(1):57-64. PubMed ID: 27177016
[TBL] [Abstract][Full Text] [Related]
24. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
25. Control of glioma cell death and differentiation by PKM2-Oct4 interaction.
Morfouace M; Lalier L; Oliver L; Cheray M; Pecqueur C; Cartron PF; Vallette FM
Cell Death Dis; 2014 Jan; 5(1):e1036. PubMed ID: 24481450
[TBL] [Abstract][Full Text] [Related]
26. OCT4 maintains self-renewal and reverses senescence in human hair follicle mesenchymal stem cells through the downregulation of p21 by DNA methyltransferases.
Lu Y; Qu H; Qi D; Xu W; Liu S; Jin X; Song P; Guo Y; Jia Y; Wang X; Li H; Li Y; Quan C
Stem Cell Res Ther; 2019 Jan; 10(1):28. PubMed ID: 30646941
[TBL] [Abstract][Full Text] [Related]
27. Novel Cancer Stem Marker and Its Applicability for Grading Primary Human Gliomas.
Dolgova EV; Mishinov SV; Proskurina AS; Potter EA; Efremov YR; Bayborodin SI; Tyrinova TV; Stupak VV; Ostatin AA; Chernykh ER; Bogachev SS
Technol Cancer Res Treat; 2018 Jan; 17():1533034617753812. PubMed ID: 29375020
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-Mediated Epigenetic Regulation of Stemness in Brain Tumor Cells.
Prasad P; Mittal SA; Chongtham J; Mohanty S; Srivastava T
Stem Cells; 2017 Jun; 35(6):1468-1478. PubMed ID: 28376560
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant glioma grade.
Teng Y; Dong YC; Liu Z; Zou Y; Xie H; Zhao Y; Su J; Cao F; Jin H; Ren H
Int J Mol Med; 2017 Mar; 39(3):725-733. PubMed ID: 28204824
[TBL] [Abstract][Full Text] [Related]
30. Allelic expression and DNA methylation profiles of promoters at the parental Oct4 and Nanog genes in Mus musculus ES cell/Mus caroli splenocyte hybrid cells.
Battulin NR; Pristyazhnyuk IE; Matveeva NM; Fishman VS; Vasilkova AA; Serov OL
Cell Tissue Res; 2009 Sep; 337(3):439-48. PubMed ID: 19609564
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of DNA methylation alterations in paediatric glioma stem cells following fractionated dose irradiation.
Danielsson A; Barreau K; Kling T; Tisell M; Carén H
Clin Epigenetics; 2020 Feb; 12(1):26. PubMed ID: 32046773
[TBL] [Abstract][Full Text] [Related]
32. Establishment of oct4:gfp transgenic zebrafish line for monitoring cellular multipotency by GFP fluorescence.
Kato H; Abe K; Yokota S; Matsuno R; Mikekado T; Yokoi H; Suzuki T
In Vitro Cell Dev Biol Anim; 2015 Jan; 51(1):42-9. PubMed ID: 25515246
[TBL] [Abstract][Full Text] [Related]
33. RhoGDIα suppresses self-renewal and tumorigenesis of glioma stem cells.
Wu F; Hu P; Li D; Hu Y; Qi Y; Yin B; Jiang T; Yuan J; Han W; Peng X
Oncotarget; 2016 Sep; 7(38):61619-61629. PubMed ID: 27557508
[TBL] [Abstract][Full Text] [Related]
34. SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.
Murakami S; Ninomiya W; Sakamoto E; Shibata T; Akiyama H; Tashiro F
Stem Cells; 2015 Sep; 33(9):2652-63. PubMed ID: 26013162
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.
Freberg CT; Dahl JA; Timoskainen S; Collas P
Mol Biol Cell; 2007 May; 18(5):1543-53. PubMed ID: 17314394
[TBL] [Abstract][Full Text] [Related]
36. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies.
Hoffmann MJ; Müller M; Engers R; Schulz WA
Biochem Pharmacol; 2006 Nov; 72(11):1577-88. PubMed ID: 16854382
[TBL] [Abstract][Full Text] [Related]
38. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
[TBL] [Abstract][Full Text] [Related]
39. Distinctive expression pattern of OCT4 variants in different types of breast cancer.
Soheili S; Asadi MH; Farsinejad A
Cancer Biomark; 2017; 18(1):69-76. PubMed ID: 27814277
[TBL] [Abstract][Full Text] [Related]
40. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
